share_log

百诚医药:国金证券股份有限公司关于杭州百诚医药科技股份有限公司2024年半年度持续督导跟踪报告

Hangzhou Bio-Sincerity Pharma-Tech: Sinolink Securities Co., Ltd.'s Continuous Supervision and Follow-up Report on Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.'s 2024 Half-Yearly

SZSI ·  Aug 14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more